Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

ROCCA, BIANCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 223
NA - Nord America 49
EU - Europa 48
AF - Africa 1
Totale 321
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 191
US - Stati Uniti d'America 35
HK - Hong Kong 27
DE - Germania 10
AT - Austria 8
CA - Canada 7
IT - Italia 7
GB - Regno Unito 6
CU - Cuba 4
ES - Italia 4
FI - Finlandia 3
BE - Belgio 2
FR - Francia 2
MX - Messico 2
VN - Vietnam 2
BG - Bulgaria 1
CH - Svizzera 1
EE - Estonia 1
HN - Honduras 1
IE - Irlanda 1
IS - Islanda 1
KR - Corea 1
LA - Repubblica Popolare Democratica del Laos 1
SA - Arabia Saudita 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 321
Salva come PNG Salva come JPEG
Città #
Singapore 141
Hong Kong 27
Toronto 5
Falkenstein 4
Havana 4
Los Angeles 4
Helsinki 3
Brussels 2
Culiacán 2
Ho Chi Minh City 2
Leipzig 2
London 2
Miami 2
Ottawa 2
Parma 2
San Jose 2
Vienna 2
Vigo 2
Atlanta 1
Bratislava 1
Dublin 1
Fermo 1
Madrid 1
Mountain View 1
New York 1
Orlando 1
Phoenix 1
Reykjavik 1
Riyadh 1
Sofia 1
Tallinn 1
Vientiane 1
Zurich 1
Totale 225
Salva come PNG Salva come JPEG
Nome #
2024 EACTS Guidelines on perioperative medication in adult cardiac surgery 16
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 11
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy 9
Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH 8
Effect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B2 and 8-iso-prostaglandin F2α, levels in human urine samples by validated enzyme immunoassays 7
The ESC Working Group on Cardiovascular Pharmacotherapy: continuity through transformation 7
Reprogramming Epigenetic Changes Blunts p66Shc-induced Vascular Dysfunction In Experimental and Human Obesity: Insights for Mechanisms-Based Therapeutic Strategies 7
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 6
Update on antithrombotic therapy and body mass. A Clinical consensus Statement of the ESC Working Group on Cardiovascular Pharmacotherapy and the ESC Working Group on Thrombosis 6
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA) 6
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) 6
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial 6
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis 5
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes 5
A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation 5
Acceptability of aspirin for cancer preventive therapy: a survey and qualitative study exploring the views of the UK general population 5
2023 ESC Guidelines for the management of acute coronary syndromes 5
Infective Endocarditis and Antithrombotic Therapy 5
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases 5
Farmaci antipiastrinici 5
Abnormal Megakaryopoiesis and Platelet Function in Cyclooxygenase-2-Deficient Mice 5
Fertility following solid organ transplantation 5
The lifespan determinant p66shc drives obesity-induced oxidative stress, mitochondrial dysfunction and vascular inflammation 4
Ticagrelor and Statins: Dangerous Liaisons? 4
Pseudo-acquired vWD in essential thrombocythemia: the role of platelets 4
Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A new perspective 4
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 4
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 4
A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation 4
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes Mellitus 4
Impact of COX-2 deletion on platelet and megakaryocyte phenotypes 4
EQUIVALENZE DI CLASSE TE RAPEUTICA NELL'AREA DEGLI ANTICOAGULANTI ORALI 4
Twice Daily Dosing Normalyzes the Impaired Antiplatelet Effect of Low-Dose Aspirin Due to Enhanced Platelet Turnover in Patients Undergoing On-Pump Cardiac Surgery 4
Platelet reactivity in patients with stable cardiovascular disease using aspirin: correlation between different tests and association with subject characteristics 4
Genetic Deletion of P66 (Shc) Protects Against Obesity-Induced Mitochondrial Dysfunction, Oxidative Stress and Vascular Inflammation 4
Another family with IGPS 4
Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis 4
Platelet and megakaryocyte phenotypes of COX-2 deletion 4
Illustrated State-of-the-Art Capsules of the ISTH 2022 Congress 4
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 4
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial 3
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a joint position paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI) 3
Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis 3
Expression and activity of cyclooxygenase isoforms in skeletal muscles and myocardium of humans and rodents 3
The search for optimal antithrombotic therapy in transcatheter aortic valve implantation: facts and uncertainties 3
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: A joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA) 3
Prostaglandin E2 differentially modulates human platelet function through the EP2 and EP3 receptors 3
In Vivo Platelet Activation in Impaired Glucose Tolerance and During Progression of Type 2 Diabetes: a Cross-sectional and Longitudinal Study 3
Characterization of aspirin esterase activity in health and disease: In vitro and ex vivo studies 3
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes 3
Cardiovascular responses to the isoprostanes iPF(2alpha)-III and iPE(2)-III are mediated via the thromboxane A(2) receptor in vivo 2
Platelet progenitors: the hidden drug target 2
Epstein syndrome: another renal disorder with mutations in the nonmuscle myosin heavy chain 9 gene 2
Impaired primary hemostasis with normal platelet function in Duchenne muscular dystrophy during highly-invasive spinal surgery 2
Personalized medicine, pharmacogenetics, and clopidogrel: Unraveling variability of response 2
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 2
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 2
Effect of low-dose and standard-dose aspirin on PGE2 biosynthesis among individuals with colorectal adenomas: A randomized clinical trial 2
The Key Contribution Of Platelet And Vascular Arachidonic Acid Metabolism To The Pathophysiology Of Atherothrombosis 2
Determinants of the Interindividual Variability in Response to Antiplatelet Drugs 2
Measurement of Thromboxane Biosynthesis in Health and Disease 2
Nonsteroidal Antiinflammatory Drugs: Past, Present and Future 2
Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis 2
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 2
In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythemia 2
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 2
Antithrombotic therapy and revascularisation strategies in people with diabetes and coronary artery disease 2
Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017, Charité, Berlin 2
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer 2
Antithrombotic therapy and revascularisation strategies in people with diabetes and coronary artery disease 2
Characterization of biochemical and functional effects of antiplatelet drugs as a key to their clinical development 2
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 2
Antithrombotic therapy in diabetes: which, when, and for how long? 2
The linkage between binding of C-terminal domain of hirudin and amidase activity in human alpha-thrombin 2
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector 2
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 2
Cyclooxygenase 2 expression and inhibition in atherothrombosis 2
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy 2
Cancer and cardiovascular diseases: the long, winding and crossing roads 2
Pregnancy after liver transplantation: report of 8 new cases and review of the literature 2
The Interplay between Indoleamine 2,3-Dioxygenase 1 (IDO1) and Cyclooxygenase (COX)-2 In Chronic Inflammation and Cancer 2
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 2
Kinetics of free platelet decrease after ADP: effect of fibrinogen binding inhibitors 2
Cyclooxygenase-2 expression is induced during megakaryopoiesis and characterizes newly formed platelets 2
Prevention Italy 2021 - An update of the 2018 Consensus document and recommendations for the prevention of cardiovascular disease in Ital 2
Platelets, coagulation and the vascular wall The quest to better understand and smarten up our therapeutic targeting of this triad in primary and secondary prevention of cardiovascular events 2
TNF-related apoptosis-inducing ligand (TRAIL) up-regulates cyclooxygenase (COX)-1 activity and PGE(2) production in cells of the myeloid lineage 2
Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Acute Cardiovascular Care Association (ACCA), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e-Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS) 2
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome 2
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis 2
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation 2
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 2
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) 2
The ESC Working Group on Thrombosis. 2
Platelet Activation and Inhibition in Polycythemia Vera and Essential Thrombocythemia 2
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 2
Aspirin at 120: Retiring, recombining, or repurposing? 2
Fibrinogen-elongated gamma chain inhibits thrombin-induced platelet response, hindering the interaction with different receptors 2
Increased thromboxane metabolites excretion in liver cirrhosis. 2
Symply read: erythrocytes modulate platelet function. should we rethink the way we give aspirin? 2
Totale 347
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.860
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.860
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/2025536 0 0 0 343 104 89 0 0 0 0 0 0
Totale 536